KA(Delisted)
Kineta·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 1
Bearish signal 0
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About KA
Kineta Inc
A company that develops therapies for alzheimer disease, parkinson disease and amyotrophic lateral sclerosis
7683 SE 27th Street, Suite 481, Mercer Island, WA 98040
--
Kineta Inc was incorporated in Delaware on December 13, 2006. The company is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that can transform patients' lives. Using its expertise in innate immunity, Kineta focuses on discovering and developing potentially differentiated immunotherapies to address the major challenges of current cancer therapies.
Company Financials
EPS
KA has released its 2024 Q1 earnings. EPS was reported at -0.89, versus the expected -0.21, missing expectations. The chart below visualizes how KA has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
